User profiles for Jose Miramontes

José Cabral Miramontes

Universidad Autónoma de Nuevo León
Verified email at uanl.edu.mx
Cited by 674

Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART Registry (Spanish Familial …

…, M Mauri, T Padró, JP Miramontes… - … and Vascular Biology, 2016 - Am Heart Assoc
Objective— Heterozygous familial hypercholesterolemia (FH) is the most common premature
atherosclerotic cardiovascular disease (ASCVD)–related monogenic disorder, and it is …

The effects of ethnicity and language on medical outcomes of patients with hypertension or diabetes

…, A Napoles-Springer, JM Miramontes - Medical care, 1997 - journals.lww.com
Limited research has compared the well-being functioning of patients from different ethnic
backgrounds with chronic medical conditions. Given that ethnic differences in attitudes, beliefs…

Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: insights from SAFEHEART registry

…, R Argueso, P Prieto-Matos, JP Miramontes… - Journal of Clinical …, 2016 - Elsevier
Background Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder
associated with very high levels of cholesterol, accelerated atherosclerosis and very …

mHealth app using machine learning to increase physical activity in diabetes and depression: clinical trial protocol for the DIAMANTE Study

…, A Cemballi, L Gomez-Pathak, J Miramontes… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Depression and diabetes are highly disabling diseases with a high prevalence
and high rate of comorbidity, particularly in low-income ethnic minority patients. Though …

Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from …

…, JL Díaz-Díaz, D Zambón, JP Miramontes… - Journal of Clinical …, 2018 - Elsevier
Background Familial hypercholesterolemia (FH) confers an increased risk of premature
atherosclerotic disease. Coronary computed tomographic angiography (CTA) can assess …

Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)

…, T Padró, R Argueso, JP Miramontes-González… - Circulation, 2017 - Am Heart Assoc
Background: Although risk factors for atherosclerotic cardiovascular disease (ASCVD) in
familial hypercholesterolemia (FH) have been described, models for predicting incident ASCVD …

Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up

…, C Martinez-Faedo, JP Miramontes-Gonzalez… - Journal of the American …, 2016 - jacc.org
Background : Familial hypercholesterolemia (FH) is the most common genetic disorder
associated with premature atherosclerotic cardiovascular disease (ASCVD). There are sparse …

[HTML][HTML] Corrosion resistance of aluminum alloy AA2024 with hard anodizing in sulfuric acid-free solution

JC Miramontes, C Gaona Tiburcio, E García Mata… - Materials, 2022 - mdpi.com
In the aeronautical industry, Al-Cu alloys are used as a structural material in the manufacturing
of commercial aircraft due to their high mechanical properties and low density. One of the …

[HTML][HTML] Developing messaging content for a physical activity smartphone app tailored to low-income patients: user-centered design and crowdsourcing approach

…, R Hernandez-Ramos, J Miramontes… - JMIR mHealth and …, 2021 - mhealth.jmir.org
Background Text messaging interventions can be an effective and efficient way to improve
health behavioral changes. However, most texting interventions are neither tested nor …

Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study

…, JL Díaz-Díaz, D Zambón, JP Miramontes… - Atherosclerosis, 2021 - Elsevier
Background and aims Heterozygous familial hypercholesterolemia (FH) is associated with
premature atherosclerotic cardiovascular disease. Semi-automated plaque characterization (…